Ceftizoxime

Kathryn Dzintars, Pharm.D., BCPS, Paul A. Pham, Pharm.D.

INDICATIONS

INDICATIONS

INDICATIONS

FDA

FDA

FDA

  • No longer available in the U.S.
  • Lower respiratory tract infections
  • Urinary tract infections
  • Gonorrhea including uncomplicated cervical and urethral gonorrhea
  • Pelvic inflammatory disease caused by N. gonorrhoeae, E. coli or S. agalactiae
  • Intra-abdominal infections (author’s comment: avoid in severe intra-abdominal infections)
  • Septicemia caused by S. pneumoniae, MSSA, E. coli,Bacteroides spp. including B. fragilis, Klebsiella spp. and Serratia spp. (must confirm sensitivity)
  • Skin and skin-structure infections (not MRSA)
  • Bone and joint infections
  • Meningitis caused by H. influenzae (limited data with S. pneumoniae)

NON-FDA APPROVED USES

NON-FDA APPROVED USES

NON-FDA APPROVED USES

  • Septic arthritis, community-acquired
  • Genital ulcer adenopathy syndrome

There's more to see -- the rest of this topic is available only to subscribers.

© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.